Building Non-Communicable Eye Disease Research Capacity in India
Building Non-Communicable Eye Disease Research Capacity in India
批准号:
10491736
负责人:
DAVID C MUSCH
金额:
$22.36万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-20 至 2026-07-31
关键词:
AddressAgeAgingAmericanBlindnessCapsicumClinicalClinical ResearchClinical and Translational Science AwardsCollaborationsDementiaEducational StatusElderlyEnvironmentEpidemicEyeEye diseasesFacultyFundingGrantHomeHospitalizationIndiaInstitutionInterventionKnowledgeMental DepressionMentorsMethodsMichiganNeeds AssessmentPopulationRecording of previous eventsResearchResearch PersonnelResearch TrainingRisk FactorsRoleSensorySurveysTrainingTraining ActivityTraining ProgramsUnited States National Institutes of HealthUniversitiesVisionVisualVisual impairmentaging populationbaseblindcare systemscareerdesigndisabilityeducation researchepidemiology studyfall riskmiddle agemortalitypopulation healthprogramsskillssuccesstraining opportunityyears lived with disability
中文摘要
摘要
印度是世界上超过17%的人口和25%的盲人或视障人士的家园
全世界。在印度,失明和视力障碍是导致多年残疾的第四大原因
而且是70岁及以上人群的头号原因,这是印度人口中迅速增长的一部分
不断增长。在印度,90%以上的失明是由于非传染性疾病造成的,其中大部分是
是可以避免的。视力不佳与广泛的后果有关,包括摔倒的风险增加。
痴呆症、抑郁症、残疾、丧失独立性、更长时间和更频繁的住院,以及
死亡率上升。尽管非传染性眼病的负担很大,而且不断增加,特别是
在老年人中,印度缺乏研究专业知识来表征这种流行病并了解其
原因和后果是有效干预和减少人口健康的关键障碍
冲击力。因此,这次培训的重点是建设临床流行病学研究能力,
强调生命过程分析在非传染性眼病研究中的应用
上了年纪的人。鉴于印度人口老龄化和NCED对老年人的不成比例影响
印度人,培训印度视觉研究人员的研究原则和方法是至关重要的,这将使
以有效地满足这一关键需求。此外,我们目前缺乏来自生命历程的知识
了解早年和中年暴露对晚年视力和视力相关的影响的角度
印度的残疾问题。针对印度背景的研究对于确定关键风险因素和残疾至关重要
NCED的后果,并制定有效的有针对性的干预措施。拟议的研究
能力建设方案将利用Aravind眼科护理的特殊机构环境
印度和密歇根大学(UM)的AECS系统,包括NIH资助的密歇根大学克劳德·D。
胡椒老年美国人独立中心和临床与翻译科学奖。UM和
AECS有着悠久的合作和教育交流的历史。根据一项
需求评估调查、博士和硕士级别的培训轨道已设计为满足需求
职业生涯早期和中期渴望从事临床流行病学研究的AECS教员。的目标是
这项计划包括:1)提供全面的研究生水平的培训,指导临床和
对将在NCED和NCED中担任领导角色的AECS受训人员进行流行病学研究
印度的感官衰老研究;2)发展AECS教师的指导和研究教育技能;
以及3)在AECS建立面向广大地区受众的研究培训机会。全
培训活动将在5年授权期结束时过渡到AECS。这两个合作机构
致力于该培训计划的成功及其强大的潜力,以应对日益增长的
NCED和视力残疾在印度迅速老龄化的人口中的流行。
英文摘要
ABSTRACT
India is home to over 17% of the world’s population and to 25% of those who are blind or visually impaired
worldwide. Blindness and vision impairment are the fourth leading cause of years lived with disability in India
and are the number one cause in those age 70 and older, a segment of the Indian population that is rapidly
growing. Over 90% of vision loss in India is due to non-communicable disease, the majority of which is
avoidable. Poor vision is associated with wide-reaching consequences, including an increased risk of falls,
dementia, depression, disability, loss of independence, longer and more frequent hospitalizations, and
increased mortality. Despite the large and growing burden of non-communicable eye disease, particularly
among older adults, the shortage of research expertise in India to characterize the epidemic and understand its
causes and consequences is a critical barrier to intervening effectively and reducing its population health
impact. Therefore, the focus of this training program is on building clinical-epidemiological research capacity,
with an emphasis on lifecourse analyses applied to the study of non-communicable eye disease (NCED) in
older adults. Given the aging of the Indian population and the disproportionate impact of NCED on older
Indians, it is critical to train Indian vision researchers in the research principles and methods that will enable
them to effectively address this critical need. Moreover, we currently lack knowledge from a lifecourse
perspective to understand the effects of early- and mid-life exposures on late-life vision and vision-related
disability in India. Research specific to the Indian context is vital to determine key risk factors and disability
consequences of NCED, and to develop effective contextualized interventions. The proposed research
capacity building program will draw upon the exceptional institutional environments at the Aravind Eye Care
System (AECS) in India and at the University of Michigan (UM), including the NIH-funded UM Claude D.
Pepper Older Americans Independence Center and Clinical and Translational Science Award. The UM and
AECS have a long-standing history of collaboration and educational exchanges. Based on the results of a
needs assessment survey, doctoral- and masters-level training tracks have been designed to meet the needs
of early- and mid-career AECS faculty who aspire to careers in clinical-epidemiological research. The aims of
this program include: 1) to provide comprehensive graduate-level training in the conduct of clinical and
epidemiologic research for trainees from AECS who will be equipped to take a leading role in NCED and
sensory aging research in India; 2) to develop the mentoring and research education skills of AECS faculty;
and 3) to establish research training opportunities at AECS that are offered to a broad regional audience. All
training activities will be transitioned to AECS by the end of the 5-year grant period. Both partner institutions
are dedicated to the success of this training program and to its strong potential to address the growing
epidemic of NCED and visual disability among India’s rapidly aging population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Building Non-Communicable Eye Disease Research Capacity in India
-
批准号:10300299
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2021
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women
-
批准号:9764737
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2019
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women
-
批准号:9892014
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the impact of glaucoma and its treatment on the person
-
批准号:8953499
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2015
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the impact of glaucoma and its treatment on the person
-
批准号:9124908
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2015
-
负责人:DAVID C MUSCH
-
依托单位:
Statins To Prevent Progression of Glaucoma: The STOP Glaucoma Trial
-
批准号:8445488
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2012
-
负责人:DAVID C MUSCH
-
依托单位:
Insights on Glaucoma from Analysis of the CIGTS Data
-
批准号:8289417
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:DAVID C MUSCH
-
依托单位:
Insights on Glaucoma from Analysis of the CIGTS Data
-
批准号:8111469
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2011
-
负责人:DAVID C MUSCH
-
依托单位:
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data
-
批准号:7532409
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2008
-
负责人:DAVID C MUSCH
-
依托单位:
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data
-
批准号:7675988
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2008
-
负责人:DAVID C MUSCH
-
依托单位:
Analysis of CIGTS Visual Field Data
-
批准号:6819175
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2004
-
负责人:DAVID C MUSCH
-
依托单位:
Analysis of CIGTS Visual Field Data
-
批准号:6929275
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2004
-
负责人:DAVID C MUSCH
-
依托单位:
CORNEAL ASTIGMATISM FOLLOWING PENETRATING KERATOPLASTY
-
批准号:3426368
-
项目类别:
-
资助金额:$2.24万
-
财政年份:1986
-
负责人:DAVID C MUSCH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: